瑞德西韦治疗新型冠状病毒肺炎相关的显著窦性心动过缓：1例病例及文献综述
Marked Sinus Bradycardia Associated With Remdesivir in COVID-19: A Case and Literature Review.
作者信息
Gubitosa James C, Kakar Parul, Gerula Christine, Nossa Hernando, Finkel Diana, Wong Kristin, Khatri Megna, Ali Hasan
机构信息
Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey.
Department of Cardiology, Rutgers New Jersey Medical School, Newark, New Jersey.
出版信息
JACC Case Rep. 2020 Nov 18;2(14):2260-2264. doi: 10.1016/j.jaccas.2020.08.025. Epub 2020 Oct 28.
Remdesivir has seen extensive use during the coronavirus disease-2019 pandemic given its clinically proven efficacy against severe acute respiratory syndrome coronavirus type 2. There has been little cited regarding adverse effects. Here we present the case of a patient with marked sinus bradycardia that began acutely on initiation of remdesivir and resolved almost immediately on cessation of the drug. ().
鉴于瑞德西韦对严重急性呼吸综合征冠状病毒2型具有临床验证的疗效，在2019年冠状病毒病大流行期间已被广泛使用。关于其不良反应的报道很少。在此，我们报告一例患者，在开始使用瑞德西韦后急性出现显著窦性心动过缓，停药后几乎立即缓解。（）
Zotero 插件